Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%) NATCO Pharma informs about press release
Date: 20-01-2022Pursuant to the Regulation 30 of SEBI (LODR) Regulations, 2015, NATCO Pharma has informed that it enclosed the Press Release on January 20,2022 titled ‘NATCO announces License Agreement with the Medicines Patent Pool’.
The above information is a part of company’s filings submitted to BSE.